Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
B
Details...
Enter Symbol
Vical Incorporated (NASDAQ: VICL)
Sector: Medical
Current Price :
$3.63
52 Week Low
$2.74
52 Week High
$4.58
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
86M
Market Cap:
$0.33B
Avg Volume:
660830
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
Vical (VICL) Licenses Vaxfectin Adjuvant For Use In Malaria Vaccines To Cyvax
Dec 05, 2012 07:38 AM |
VICL
Stocks Jump As Fed Acts To Spur Growth; Equinix (EQIX) Surges
Sep 13, 2012 04:21 PM |
AAPL
,
CRBC
,
CRTX
,
DST
,
DSW
,
EQIX
Vical (VICL) Announces Start Of Clinical Trial For DNA Vaccine With Vaxfectin
Mar 05, 2012 07:03 AM |
VICL
More Articles on VICL..
Press Releases
Vical Reports First Quarter 2013 Financial Results and Progress in Key Development Programs
May 09, 2013 06:30 AM |
VICL
Vical to Present at May Investor Conferences
May 07, 2013 06:30 AM |
VICL
Vaxfectin(R) Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
May 06, 2013 06:30 AM |
BAX
,
VICL
More Press Releases on VICL..
SEC Filings
Form 4 VICAL INC For: Sep 04 Filed by: SINGER JAMES R (10K)
Jan 15, 2013 11:17 AM
Form 4 VICAL INC For: Jul 19 Filed by: SINGER JAMES R (10K)
Jan 15, 2013 10:46 AM
Form 4 VICAL INC For: Oct 19 Filed by: CAMPBELL ROBERT H (10K)
Nov 28, 2012 04:29 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
VICL
Compare to S&P
YTD
31.10 %
20.22 %
4 Weeks
-0.39 %
-0.29 %
12 Weeks
14.22 %
10.38 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
0.00 %
EPS Growth in Last Year:
0.00 %
Sales Growth in Last Quarter:
6.62 %
Sales Growth in Last Quarter:
20.03 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##